Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia

Bob Olsson; Margareta Jernås; Hans Wadenvik

doi:10.1160/TH12-01-0012

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2012; 107(06): 1182-1184
DOI: 10.1160/TH12-01-0012

Letters to the Editor

Schattauer GmbH

Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia

Bob Olsson

¹Department of Internal Medicine, University of Gothenburg, Gothenburg, Sweden

,

Margareta Jernås

¹Department of Internal Medicine, University of Gothenburg, Gothenburg, Sweden

,

Hans Wadenvik

¹Department of Internal Medicine, University of Gothenburg, Gothenburg, Sweden

References
1 Harrington WJ, Minnich V, Hollingsworth JW. et al. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951; 38: 1-10.
2 Brighton TA, Evans S, Castaldi PA. et al. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 1996; 88: 194-201.
3 McMillan R, Wang L, Tani P. Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Haemost 2003; 1: 485-491.
4 Warner MN, Moore JC, Warkentin TE. et al. A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol 1999; 104: 442-447.
5 Stockelberg D, Hou M, Jacobsson S. et al. Evidence for a light chain restriction of glycoprotein Ib/IX and IIb/IIIa reactive antibodies in chronic idiopathic thrombocytopenic purpura (ITP). Br J Haematol 1995; 90: 175-179.
6 Hou M, Stockelberg D, Kutti J. et al. Antibodies against platelet GPIb/IX, GPIIb/IIIa, and other platelet antigens in chronic idiopathic thrombocytopenic purpura. Eur J Haematol 1995; 55: 307-314.
7 Ballem PJ, Segal GM, Stratton JR. et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 1987; 80: 33-40.
8 McMillan R, Wang L, Tomer A. et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2004; 103: 1364-1369.
9 Olsson B, Andersson PO, Jernas M. et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 2003; 9: 1123-1124.
10 Chow L, Aslam R, Speck ER. et al. A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy. Blood 2010; 115: 1247-1253.
11 Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995; 377: 446-448.
12 Martinvalet D, Dykxhoorn DM, Ferrini R. et al. Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death. Cell 2008; 133: 681-692.
13 Fan Z, Beresford PJ, Oh DY. et al. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003; 112: 659-672.
14 Zhang D, Pasternack MS, Beresford PJ. et al. Induction of rapid histone degradation by the cytotoxic T lymphocyte protease Granzyme A. J Biol Chem 2001; 276: 3683-3690.
15 Zhang F, Chu X, Wang L. et al. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. Eur J Haematol 2006; 76: 427-431.
16 Zhao C, Li X, Zhang F. et al. Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies. Haematologica 2008; 93: 1428-1430.